FDA lacks comprehensive data to determine whether risk evaluation and mitigation strategies improve drug safety.
- Physical Description: 1 online resource (34 pages) : illustrations
- Publisher: [Washington, D.C.] : Department of Health and Human Services, Office of Inspector General, 2013.
|General Note:|| Title from title screen (viewed June 13, 2016).
|Bibliography, etc. Note:|| Includes bibliographical references.
Search for related items by subject
United States. Food and Drug Administration > Auditing.
Drugs > Risk assessment > United States > Evaluation.
Drugs > United States > Safety measures > Evaluation.